baber/WOPTO huggingface dataset:
Patent IE-870197-L (IE)
Title: Coating compositions
IPC: C09D5/28
Filed: 1987-01-26
Abstract: This invention concerns the production of textured surfaces, and in particular to compositions for producing such surfaces. The compositions include a radiation-curable component, an adhesion promoter for promoting adhesion to a substrate, and a texture-modifying amount of microspheres substantially homogeneously dispersed therein. The microspheres can be of glass, ceramic or polymeric materials, and they can be solid or hollow. Various adhesion promoters can be used, and in general the choice will depend upon the curable system used. For example, certain polymers, monomers or unreactive volatile solvents can be used as adhesion promoters with free-radical curable compositions. Texturing can be effected on the surface of a variety of materials, for example on plastics or cellulosic substrates.
[EP0235914A2]
Patent IE-32432-L (IE)
Title: Formulations containing alkoxybenzamide
IPC: A61J7/00
Filed: 1968-02-19
Abstract: 1,209,849. Compositions comprising orthoalkoxybenzamides. COLGATE-PALMOLIVE CO. 15 Feb., 1968 [20 Feb., 1967], No. 7524/ 68. Heading A5B. An analgesic composition in the form of a nebulizer solution or a sublingual tablet comprises an ortho-alkoxybenzamide containing 1-5 carbon atoms in the alkoxy group and a compatible non-toxic carrier which affords rapid and substantially complete absorption of the ortho-alkoxybenzamide by an oral mucous membrane contiguous to the systemic circulatory system when in contact with the same, the carrier being (1) an aqueous mixture of ethanol and propylene glycol, the ethanol content not exceeding 18% by weight of the composition, or (2) a mixture comprising starch and a sweetener and flavour. Other active ingredients such as acetyl salicylic acid, chlorpheniramine, 2-(diphenyl-methoxy)-N,N-dimethylethylamine HCl, isoproterenol, ephedrine, pentobarbital, meprobamate, styramate, chlordiazepoxide HCl, dexamethane sulphate, atropine sulphate and dextromethorphan HBr may also be present.
[GB1209849A]
Patent IE-820210-L (IE)
Title: Rotary hydraulic device
IPC: F04C2/356
Filed: 1982-01-29
Abstract: 1. A rotary hydraulic device with an inner stator and an outer cage rotor comprising two series of vanes axially slidable on either side of stator bottom part, characterized in that the stator bottom part is limited to at least one radial branch (3A) presenting on either part thereof an area (5) and two ramps (4) on either side of such area, the vanes (2-2A) of both series being designed for meeting together in a zone without any stator bottom, such disposal limiting at the utmost the frictional effects between the vanes and the stator bottom only consisting of the areas (5) and the ramps (4).
Patent IE-36214-L (IE)
Title: Shaping thermoplastics tubes.
IPC: F16J13/02
Filed: 1972-03-23
Abstract: A method and device for forming grooves in a thermoplastic pipe, by surrounding said pipe with a mould having one or more grooves in its interior wall and positioning one or two annular chambers into said pipe, a flexible sealing circular body being sealingly movable in said chamber, and the outer circumference of said body in its free state being substantially equal to the inner circumference of the mould part facing said ring minus about twice the wall thickness of the pipe in its final state. The circular body can be retracted into the annular chamber which is provided with a bottom part having a clover-leaf-like cross section, the circumference of said cross section being substantially equal to the inner circumference of said circular body.
[US4077758A]
Patent IE-33786-L (IE)
Title: Pyrimidine nucleosides
IPC: C07D239/00
Filed: 1970-04-13
Abstract: 1313411 Protected pyrimidine nucleosides SCHERING AG 13 April 1970 [11 April 1969 23 Aug 1969] 17443/70 Heading C2C Pyrimidine nucleosides in which the hydroxyl groups in the sugar moiety are protected are prepared by reaction of a 1-O-acyl-, 1-O-alkyl- or 1-halogeno-sugar in which the hydroxyl groups are protected with a pyrimidine derivative containing at least one group selected from O-, S- and N-alkyl and -silyl groups, in the presence of a Lewis acid that is soluble in an organic solvent. The sugar is preferably ribose, deoxyribose, arabinose or glucose and the pyrimidine derivative is preferably of the general formula wherein R is a hydrogen or halogen atom or a C 1-4 alkyl, nitro or cyano group, E is a silylated or alkylated O- or S-group, D is a silylated or alkylated O- or B-N-group, in which B is a hydrogen atom or an alkyl, aryl or aralkyl group and Y is a nitrogen atom or a CH group. The protecting groups may be acetyl, benzoyl, p-chlorobenzoyl, p-nitrobenzoyl, p-toluyl and benzyl groups.
[GB1313411A]
Patent FI-821406-L (FI)
Inventor: BROWNBILL THOMAS DUNCAN
IPC: B65D25/32
Filed: 1982-04-22
Abstract: A plastics member (16) is sealingly secured to a sheet metal member (10) by creating in the sheet metal member (10) an opening which is defined by a free edge (14) of the sheet metal, forming-up a marginal region (12) of the sheet metal member (10) around the location of the opening, receiving the plastics member (16) in the opening, and re-forming the marginal region (12) so as to close the opening onto the plastics member (16) and cause the free edge (14) to bite into and seal around the plastics member (16).
Patent IE-871188-L (IE)
Title: Fruit juice beverage supplemented with calcium
IPC: A23L2/38
Filed: 1987-05-11
Abstract: Fruit juice beverages and juice concentrates nutritionally supplemented with significant levels of solubilized calcium are disclosed. These beverages and concentrates are substantially free of added protein, and comprise at least about 45% fruit juice. The method for preparing these beverages and concentrates involves forming a premix solution containing highly soluble calcium citrate and malate species which is then combined with concentrated fruit juice, plus other fruit juice materials. This method provides beverages and concentrates which contain substantial levels of solubilized calcium without generating cooked/browned off-flavors and without including undesirable species as chloride ions.
[EP0244903A1]
Patent IE-33357-L (IE)
Title: Self-crimpable polyamide fibres
IPC: D01F8/12
Filed: 1969-10-28
Abstract: 1,272,236. Self-crimpable composite polyamide fibres. E. I. DU PONT DE NEMOURS & CO. 12 Nov., 1969 [14 Nov., 1968], No. 55427/69. Heading B5B. [Also in Division C3] Self-crimpable composite fibres or filaments are comprised of at least two continuous adherent, longitudinally extending, eccentrically positioned synthetic polyamide components of different composition and shrinkage characteristics, each component being comprised of at least 50 mole per cent of at least one type of recurring units of the formula wherein x is 1 or 2, the symbols R which may be the same or different, represent hydrogen atoms and/or methyl groups, Y is 8-14 and S indicates a saturated ring, at least 40% by weight of the diamino constituent of the recurring units of the above formula being of a trans-trans stereoisomeric configuration and at least one of the components being a copolymer. Preferably the fibres or filaments consist of two components, x is 1 and R is hydrogen. At least one of the two components may consist essentially of recurring units of Formula (I). In this case at least 5% by weight of the diamino constitutents of one of the components may differ in stereoisomeric configuration from the diamino constituent in the other component. The trans-trans diamino constituent isomer content in one of the components (where two components are present) may be at least 10% lower than in the other component. In two component filaments one of the components may be a copolymer comprised of 50 to 95, preferably 70 to 90, mole per cent of at least one type of recurring unit of Formula (I). The components of two-component fibres or filaments may have a difference in shrinkability of 4-65%. In two component fibres or filaments one of the components may comprise 30-70% by weight of the filament. The composite filaments may be formed by melt-spinning in the usual manner, converged into a yarn, drawn at a draw ratio of up to 3.0 while passing round a heating element maintained at 120 C. and passed through a pressured jet at 120 C. to separate the filaments and produce a randomly crimped yarn.
[GB1272236A]
Patent IE-801809-L (IE)
Title: Cns stimulants
IPC: C07D271/04
Filed: 1980-08-28
Abstract: A compound of the formula: <IMAGE> in which the enantiomeric form is d,1 or 1- when R5 is hydrogen and d,1 or 1-threo when R5 is other than hydrogen; R1 and R2 are, independently, hydrogen, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, halo, perfluoroalkyl of 1 to 3 carbon atoms, nitro, alkanoyl of 2 to 4 carbon atoms or alkoxycarbonyl of 2 to 4 carbon atoms; R3 is hydrogen, halo, nitro or alkanoyl of 2 to 4 carbon atoms; R5 and R6 are, independently, hydrogen or methyl; or a non-toxic acid addition salt thereof, are central nervous system stimulants.
[US4277609A]
Patent IE-871959-L (IE)
Title: Method for producing indan derivatives
IPC: C07D477/20
Filed: 1987-07-20
Abstract: (4R,5S,6S,8R,2'S,4'S)-3-[4-(2-Dimethylaminocarbonyl)pyrrolidinylthio ] -4-methyl-6-(1-hydroxyethyl)-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carb oxylic acid of the formula: <CHEM> in a crystalline form, which is useful as an antibiotic agent.
[EP0256377A1]
Patent IE-40409-L (IE)
Title: Novel 2,6- disubstituted phenyl-aminoguanidine compounds
IPC: A61P9/12
Filed: 1974-10-22
Abstract: The invention relates to compounds of the general formula: R' ¦ N-R4 N ANGLE R5 ¦ ¦N-N ANGLE R3¦ R3''R6 I in which one double bond is present between the carbon atom of the guanidine moiety and one of the adjacent nitrogen atoms and R0 stands for hydrogen, halogen, hydroxy, alkoxy or alkyl (1 to 6 C), R1, R2 for halogen, hydroxy, alkyl (1 to 4 C) or alkoxy (1 to 4 C), R3, R3', R3'' for hydrogen or alkyl (1 to 4 C) on the understanding that one of the substituents R3, R3' or R3'' is absent because of the presence of the double bond, R4 for hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C) or amino optionally substituted with one or two alkyl (1 to 4 C) groups, R5, R6 for hydrogen, alkyl (1-6 C), acyl or R5 + R6 together represent an alkylidene, cyclic alklidene or aralkylidene group, AS WELL AS THE ACID ADDITION SALTS THEREOF, PROVIDED THAT, IF R4 stands for methyl and R0, R3, R3'', R5 and R6 for hydrogen, R1 and R2 may not represent methyl simultaneously, having a strong and long-acting anti-hypertensive activity.
[US3972932A]
Patent IE-862442-L (IE)
Title: Coloured thermoplastic resin composition
IPC: C09B69/00
Filed: 1986-09-12
Abstract: A colored thermoplastic resin composition is provided which comprises a thermoplastic resin and a colorant in the form of an alkyleneoxy-substituted chromophore group provided in said thermoplastic resin in a minor amount sufficient to provide coloration to said thermoplastic resin. A process for preparing colored thermoplastic resins is also provided.
Patent IE-862915-L (IE)
Title: Adjustable hinge
IPC: E05D7/04
Filed: 1986-11-05
Abstract: The adjustable door or window hinge allows the pivot axis to be adjusted in a straight line relative to the door frame in a direction perpendicular to the plane of the door frame and relative to the door in a direction parallel to the plane of the door. For this purpose, there are elongate perforations which are arranged crosswise in the hinged leaves and in each of which a bearing bush can be mounted in different positions by means of axial grooves and axial ribs.
Patent NO-800476-L (NO)
Inventor: PAULUS WILFRIED
IPC: A01N47/18
Filed: 1980-02-21
Abstract: Synergistic combinations of active compounds consisting of benzimidazolyl-alkyl-carbonates and (2,2'-dihydroxy-5,5'-dichlor)-diphenyl-methane or 2-hydroxy-diphenyl have a strong activity against micro-organisms. The combination can be employed e.g. for protecting industrial materials against microbicidal decomposition.
Patent NO-841027-L (NO)
Inventor: BAUS HEINZ GEORG
IPC: A47K3/36
Filed: 1984-03-16
Abstract: 1. Partition for a corner shower or circular shower with an upper sectional rail (8) having a guide track (40), it also being preferred if a lower sectional rail (10) with a guide track (42) is provided, with at least two flat, mutually hinged door elements (16 to 19), which can be slid in the guide track (40; 42) by means of guide elements (81; 20) in order to open up or shut off an entry opening (54), and with a flat wall element (12, 14) arranged at the side of the entry opening (54), characterized in that only the sectional rail (8, 10) is adaptable to the bent shape of the shower tray (2) in the region of the entry opening (54) and has, in horizontal plane, a curved region (22, 24) which is essentially the same size as the entry opening (54), in that the sectional rail (8, 10) has, at least on one side, a straight end region (26, 28) adjoining the curved region (22, 24) and is firmly connected to the flat wall element (12, 14) by means of said straight end region, in that the door elements (16 to 19), disposed one behind the other in series, are arranged essentially parallel behind the flat wall element (12, 14) when the entry opening (54) is opened up and are arranged polygonally therein when the entry opening (54) is shut off, in that the upper edges (21) and/or the lower edges (29) of the door elements (16 to 19) lie behind the sectional rail (8, 10), and in that the vertical pivot axis of the respective door element (16 to 19) is arranged behind the sectional rail (8, 10).
Patent NO-851021-L (NO)
Title: Fremgangsmaate til krystallisering av sukker
Inventor: SHUKLA DIPAK PRABHULAL
IPC: C13B30/02
Filed: 1985-03-15
Abstract: Sukker (sukrose eller glukose) krystalliseres ved en fremgangsmåte hvor en varm, overmettet sirup føres gjennom en kontinuerlig skrueekstruder slik at det oppnås kimdannelse i sirupen i løpet av en oppholdstid på under 25 sekunder, hvoretter sirupen temmes på en flate, f.eks. et transportbånd, for krystallisasjon uten omrøring.
Patent NO-861511-L (NO)
Title: Fremgangsmaate og blanding for kondisjonering av et vandig system.
Inventor: DAVIDSON RICHARD ROBERTSON
IPC: C02F1/52
Filed: 1986-04-17
Abstract: Fremgangsmåte for kondisjoneringsbehandling av et vandig system, f.eks. kloakkvann eller dyrefarmavfal1, ved at systemet tilsettes et jordalkalimetallhydroksyd, f.eks. kalk, et vektgivende middel, f.eks. kalsiumkarbonat, og en kationisk polyelektrolytt med høy molekylvekt, f.eks. et polyakrylamid. Hydroksydet og det vektgivende middel anvendes i et vektforhold på fra 9:1 til 1:9 og blir foretrukket blandet sammen som en vandig slurry før tilsetningen til det system som skal behandles .
Patent NO-864709-L (NO)
Inventor: MICHAELS ANGELA A
IPC: G01N33/579
Filed: 1986-11-25
Abstract: A screening method for the determination of 10⁴ gram negative bacteria per milliliter of an undiluted urine sample and a unitary screening test device for the determination of at least 10⁵ gram negative bacteria per milliliter of an undiluted urine sample. The method and test device make use of Limulus amebocyte lysate (LAL) and a synthetic substrate containing a chromogenic or fluorogenic leaving group capable of being cleaved by activated lysate. This screening method and unitary screening device provide a quick, convenient, inexpensive indication of the possible presence of a urinary tract infection caused by gram negative bacteria.
Patent NO-872018-L (NO)
Inventor: TIESLER HARTMUT
IPC: C04B30/02
Filed: 1987-05-14
Abstract: Process for obtaining an aqueous emulsion of a water-insoluble additive for insulating products made of synthetic inorganic fibres, characterised in that the insoluble additive is dispersed in the aqueous solution of a cellulose ether by means of a high-performance dispersing apparatus. The cellulose ether employed is preferably a hydroxyethyl cellulose, methyl hydroxyethyl cellulose and/or sodium carboxyethyl cellulose.
Patent NO-873611-L (NO)
Inventor: BUZAS ANDRE
IPC: C07D211/70
Filed: 1987-08-27
Abstract: Derivatives corresponding to either of the formulae which follow: 
<IMAGE>
 in which:
 - R1, R2, R3 and R4, which are identical or different, denote a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an aryloxy group or the trifluoromethyl group,
 - R denotes hydrogen, a cation, an alkyl group, an aryl group or an arylalkyl group,
 - n is equal to 0 or 1, and their pharmaceutically acceptable salts. 
<??>Application: treatment of spasmodic states and of allergies.
Patent NO-875453-L (NO)
Inventor: MARWICK WILLIAM FRANCIS
IPC: C10M105/40
Filed: 1987-12-28
Abstract: A metal-working lubricant comprises an aqueous emulsion of a) a long-chain aliphatic ester, amide, alcohol or acid, and b) as a fugitive emulsifier an ammonium or volatile amine salt or a long-chain aliphatic acid. On application to sheet, e.g. of aluminium metal with a chromate or anodic oxide protective surface layer, the water and ammonia or volatile amine evaporate to leave a storage-stable hydrophobic lubricant. The sheet can be formed or made into adhesively bonded structures of shaped components.
Patent NO-881376-L (NO)
Inventor: ZIJSLING DJURRE HANS
IPC: E21B7/06
Filed: 1988-03-28
Abstract: A tubular drill string element (1), such as a stabilizer or tool joint, comprises an outer surface (5) having in circumferential direction a ratchet profile. The ratchet profile is preferentially oriented such that it provides low resistance against right hand rotation but high resistance against left hand rotation of the drill string.
Patent NO-900989-L (NO)
Inventor: EILKEN JENS-PETER
IPC: H04L7/00
Filed: 1990-03-01
Abstract: For a CMI decoder and clock recovery device, a solution is to be specified which can be largely integrated, which does not need any separate circuit for phase calibration and amplification and which has high jitter tolerance in the entire operating range. A known CMI decoder (6, 7, 8) is associated with a clock recovery device having known elements (6, 10b, 11b) and novel elements (15, 16b, 17b). The latter receives a gate arrangement which is capable of extracting from the CMI-coded data signal (D1) more clock pulses than has hitherto been possible. Apart from delay sections (6, 15) and a clock frequency selection device (12b), all elements are located in one integrated circuit (18). Input level converters (19, 20, 21, 24, 25) and output level converters (22, 23) ensure the levels required inside and outside the integrated circuit (18). To achieve identical transit times on the data path and the clock path and since the clock frequency selection device (12b) must be arranged outside the chip, the data path is also run outside the chip for a section. The jitter tolerance of the device is therefore uninfluenced by different effects on both paths. The device can be used in digital signal multiplex devices. <IMAGE>
Patent NO-902757-L (NO)
Inventor: FELDMAN PETER ANTHONY
IPC: A61K35/16
Filed: 1990-06-21
Abstract: A method for at least partially separating vitamin K-dependent blood clotting factors from a mixture containing at least one such factor, e.g. a prothrombin complex concentrate, which comprises adsorption of said mixture on to a chelate of a polyvalent metal immobilised on an inert support, e.g. Cu<2+>-primed Chelating Sepharose, followed by elution to yield one or more fractions enriched in respect of one of said factors.
Patent NO-913923-L (NO)
Inventor: PANZERI ACHILLE
IPC: A61K31/56
Filed: 1991-10-07
Abstract: The present invention concerns steroidic 5 alpha -reductase inhibitors having the formula:  <IMAGE>  As a result of their 5 alpha -reductase inhibiting activity, these compounds are useful in the treatment of androgen dependent conditions and diseases.
Patent NO-920290-L (NO)
Inventor: EIDE OLA
IPC: C02F1/24
Filed: 1992-01-22
Abstract: A method for biological and chemical single-step purification of discharged water. A flocculant and dispersed water are used and biocatalyst particles with immobilized microorganisms or enzymes are added for the conversion of residual products in the discharged water.
Patent NO-922208-L (NO)
Inventor: DEVENTER MATTIJS OSKAR VAN
IPC: H04B10/29
Filed: 1992-06-04
Abstract: A polarisation-independent amplification device comprising an optical semiconductor amplifier. The amplification device input signal is fed to one side of the amplifier and a reflector is provided at the other side. The amplification device output signal, formed by the amplification device input signal reflected by the reflector and amplified by the amplifier, is taken off at the first side of the amplifier. The reflector is reciprocal, a signal or signal component fed thereto and having a polarisation perpendicular to the principal axis of the amplifier being reflected as a reflection signal having a polarisation which is virtually parallel to said principal axis and vice versa.
Patent NO-930200-L (NO)
Inventor: UHLMANN EUGEN
IPC: C07H21/04
Filed: 1993-01-21
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R<1> = H, a substituent or -P(=W)ZZ'; R<2> = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R<3>, R<4> = substituents; p = 1-100; q = 0-18; R<11> = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta  or a group of formula (ii);  alpha  = 1-11;  beta  = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R<2> and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha  or  beta  configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR<5>R<6>); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R<5>, R<6> = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
Patent NO-934584-L (NO)
Inventor: DOPPER JAN HENDRIK
IPC: A61K9/16
Filed: 1993-12-13
Abstract: Disclosed is a process of preparing granules involving first preparing a carrier comprising diluent, binder, and optionally a disintegrating agent. In a container separate from said carrier, a steroid, lubricant and, optionally, an antioxidant are dissolved in an, optionally pre-heated, organic solvent. The resulting solution is added to the carrier contained within an, e.g vacuum mixer, followed by further blending of the mixture. The organic solvent is removed from the mixture. The mixture is blended further to form granules. The process may further include incorporating a flow enhancer such as colloidal silicon dioxide into the granules. A granule for making a pharmaceutical dosage unit is granule characterized in comprising: a) a carrier comprising diluent and binder, and b) a film coating said carrier, said film comprising desogestrel and a lubricant, and has the characteristic of by retaining 90% of the desogestrel at a pressure of 150 mbar and at a temperature of 70 DEG  C over 72 hours.
Patent NO-942536-L (NO)
Title: Svitsjeforsterker
Inventor: TURNER WHEELER M
IPC: H03K7/08
Filed: 1994-07-05
Abstract: Oppfinnelsen angår en forbedret digital svitsjeforsterker. Forsterkeren benytter et lavpassfilter (LPF) ved inngangen til svitsje- komparatoren (Ul) for å gi et forbedret signal/ støyforhold i den endelige utgang (V ). I et annet aspekt ved oppfinnelsen, blir en forplantnings- forsinkelse benyttet til å produsere oscillasjon i forsterkerkretsen.